Trial Profile
Non-comparable and Open Clinical Research to Evaluate Long-term Immunity by Neutralizing Antibody Test of Adults in High Risk Population of HFRS (Hemorrhagic Fever With Renal Syndrome) After Vaccination and Booster Vaccination of Hantavax
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Feb 2015
Price :
$35
*
At a glance
- Drugs Hantaan virus vaccine-(Hantavax) (Primary)
- Indications Hantaan virus infections
- Focus Pharmacodynamics
- Sponsors Green Cross
- 17 Feb 2015 New trial record